Etiology, clinical features and outcomes of pre-engraftment and post-engraftment bloodstream infection in hematopoietic SCT recipients. - Wikidata - wikimedia - TriplyDB

Etiology, clinical features and outcomes of pre-engraftment and post-engraftment bloodstream infection in hematopoietic SCT recipients.

Etiology, clinical features and outcomes of pre-engraftment and post-engraftment bloodstream infection in hematopoietic SCT recipients.

http://www.wikidata.org/entity/Q42222497

about

The Changing Epidemiology of Bloodstream Infections and Resistance in Hematopoietic Stem Cell Transplantation Recipients.Infection Rates among Acute Leukemia Patients Receiving Alternative Donor Hematopoietic Cell Transplantation.Bacterial bloodstream infections in the allogeneic hematopoietic cell transplant patient: new considerations for a persistent nemesis.Incidence and risk factors of bacterial infections in children following autologous hematopoietic stem cell transplantation: Single-center experience from Jordan.MALDI-TOF MS in post-transplant bloodstream infections: reliable identification of causative bacteria in the neutropenic phase.Pre-engraftment bloodstream infections in acute leukemia patients undergoing unrelated cord blood transplantation following intensified myeloablative conditioning without ATG.Daily chlorhexidine bathing does not increase skin toxicity after remission induction or stem cell transplantation.Gut Microbiota Predict Pulmonary Infiltrates after Allogeneic Hematopoietic Cell Transplantation.Risk factors for cefepime nonsusceptible Gram-negative infections in allogeneic hematopoietic cell transplant recipients.Changes in the microbiological epidemiology of febrile neutropenia in autologous stem cell transplant recipients.Infection Complications in Hematopoietic Stem Cells Transplant Recipients: Do Genetics Really Matter?

P2860

Q37417446-A63D4E61-29AB-4CF2-BD87-0B77F2EA3446 Q38848582-7087A909-F32C-4A7D-AA70-76EA416F9190 Q39202357-B22B8010-AF5D-46F6-875B-E06D4C52FF79 Q39702433-517B96E1-C1C6-4122-820E-A3CC2B9AF237 Q40353518-9F3D0BAB-BB36-4C54-A690-1E6959045EA1 Q40490255-88FF324D-1D3D-4D38-9C0D-14C49775739B Q40689193-EEC7A90C-2290-4BAE-91BF-B93B465FC55F Q40787967-96C95C7B-BB09-4D11-B0E5-B33B0BAD3B70 Q47917729-D2973497-5046-4377-B92F-A7EBBC88B3C9 Q50119378-BB0DCD78-7DD7-43F8-AFCC-CCC4ADB048FE Q57818274-08622FC1-5638-4F2A-A180-94983AC41280

P2860

Etiology, clinical features and outcomes of pre-engraftment and post-engraftment bloodstream infection in hematopoietic SCT recipients.

http://www.wikidata.org/entity/Q42222497

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Etiology, clinical features an ...... hematopoietic SCT recipients.

@en

Etiology, clinical features an ...... hematopoietic SCT recipients.

@nl

type

label

Etiology, clinical features an ...... hematopoietic SCT recipients.

@en

Etiology, clinical features an ...... hematopoietic SCT recipients.

@nl

prefLabel

Etiology, clinical features an ...... hematopoietic SCT recipients.

@en

Etiology, clinical features an ...... hematopoietic SCT recipients.

@nl

P1433

Q42222497-E47C2A98-6BD7-4E7E-BAE6-F97167E78C4E

P1476

Q42222497-8EE5E3B6-E532-4C17-891A-8FF2950E6AC4

P2093

Q42222497-09C64452-FB3A-4E62-9B9A-DDAA7C46A83C

Q42222497-2462992A-585F-4266-AC0D-5095B10CB0D1

Q42222497-2C368B69-4F8D-4AC3-B98A-0D915A8B7F73

Q42222497-4EB9F447-3AEE-4C1A-9113-ECD005EE116B

Q42222497-815B8A0D-2197-47D9-8641-019CEDC6E98F

P2860

Q42222497-04BAE292-6A41-406A-B9CD-D7B8F7522395

Q42222497-128B688C-59B7-475C-B0EF-59EB0C7BB035

Q42222497-179A16C8-CAE5-4428-9F26-21BAA0027126

Q42222497-2164005E-2668-4634-A48F-575A79D810B7

Q42222497-29AF8106-5F0A-43D1-84CD-86C65B726994

Q42222497-398631B0-49FE-4FD5-8D7F-C2F01FEB2AA5

Q42222497-3C5A75C6-87D0-4A09-B164-B1B6D887C5F8

Q42222497-47DE9CEA-A27E-4ABD-814D-A8E5D4DF9CEB

Q42222497-4D0988E7-42A3-497E-BB95-574D70B3F5BF

Q42222497-54D3BF1B-B314-408D-9310-406304F4D812

P2888

Q42222497-885C1AA4-1408-4D21-B7EA-5A72D82B7371

P304

Q42222497-095B90EE-20C6-4E34-A00F-98AF659EAF60

P31

Q42222497-18338A80-EA58-40E5-AF17-1298DFE493C5

P356

Q42222497-CAE7E728-9873-4ECC-BAB8-68A6DD61FFCE

P407

Q42222497-6EC20A5D-1394-4E01-B822-DE756A4F401A

P433

Q42222497-FCD1BFAF-251E-495D-84D7-79A416702B12

P478

Q42222497-451B32A3-213B-4EA4-A25F-3F8C99EB4769

P50

Q42222497-957F9848-55A6-40C7-A60D-C36B1A367CC6

Q42222497-B979E6D6-FDF2-4FCA-BC25-C11C9698EA69

P577

Q42222497-540B059F-BC1A-4877-A232-927A3420E521

P5875

Q42222497-1EB4E842-73CD-4FA4-B9F3-5B9A665F45EA

P6179

Q42222497-9B9AE197-8752-4A94-BB73-4737D4EC70FC

P698

Q42222497-F112C7A0-90D7-410E-B6B3-256241EAAA9A

P356

P1433

Bone Marrow Transplantation

P1476

Etiology, clinical features an ...... hematopoietic SCT recipients.

@en

P2093

B Patiño

http://www.w3.org/2001/XMLSchema#string

C Gudiol

http://www.w3.org/2001/XMLSchema#string

I Sánchez-Ortega

http://www.w3.org/2001/XMLSchema#string

M Arnan

http://www.w3.org/2001/XMLSchema#string

R Duarte

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance

Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria.

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

Blood stream infection (BSI) and acute GVHD after hematopoietic SCT (HSCT) are associated

The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection.

Cytomegalovirus diseases after hematopoietic stem cell transplantation: a mini-review.

Unique risk factors for bacteraemia in allogeneic bone marrow transplant recipients before and after engraftment.

Corticosteroid-mediated immunoregulation in man.

Clinical efficacy and safety of primary antifungal prophylaxis with posaconazole vs itraconazole in allogeneic blood and marrow transplantation.

P2888

P304

824-830

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BMT.2014.37

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P50

Jordi Carratala

Carolina Garcia-Vidal

P577

2014-03-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261067449

http://www.w3.org/2001/XMLSchema#string

P6179

1030334580

http://www.w3.org/2001/XMLSchema#string

P698

24662420

http://www.w3.org/2001/XMLSchema#string